Doxorubicin is a type of anthracycline chemotherapy drug used to treat certain types of solid tumors and blood cancers. It has a number of side effects, some more serious than others. Experts predict ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Novel drug combinations that improve outcomes, outstanding questions about treatment sequence, and encouraging results in chemotherapy resistant disease are among the ovarian cancer highlights ...

Merck's KEYNOTE-B96 trial shows Keytruda with chemotherapy improves survival in platinum-resistant recurrent ovarian cancer with a consistent safety profile.